Niiza, Japan

Moto Morioka

This inventor holds 2 USPTO granted patents. Top assignees: Yamanouchi Pharmaceutical Company Ltd., Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1980-1981.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Niizo, JP (1980)
  • Niiza, JP (1981)

Company Filing History:


Years Active: 1980-1981

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Moto Morioka: Innovator in Aminoglycoside Antibiotics

Introduction

Moto Morioka is a notable inventor based in Niiza, Japan. He has made significant contributions to the field of biochemistry, particularly in the production of aminoglycoside antibiotics. With a total of 2 patents to his name, Morioka's work has had a lasting impact on antibiotic development.

Latest Patents

Morioka's latest patents focus on the process for the production of aminoglycoside antibiotics. These antibiotics are biochemically transformed from Kanamycin A or Kanamycin B. They are represented by specific chemical formulas, wherein R₁ represents a hydrogen atom or a methyl group, and R₂ represents an amino group or a hydroxyl group. His innovative approaches have paved the way for advancements in antibiotic therapies.

Career Highlights

Throughout his career, Morioka has worked with prominent companies in the pharmaceutical industry. Notably, he was associated with Yamanouchi Pharmaceutical Company Ltd. and the Biseibutsu Kagaku Kenkyu Kai. His work in these organizations has contributed to the development of effective antibiotic solutions.

Collaborations

Morioka has collaborated with esteemed colleagues, including Takashi Osono and Hamao Umezawa. These partnerships have fostered a collaborative environment that has enhanced research and innovation in the field of antibiotics.

Conclusion

Moto Morioka's contributions to the field of aminoglycoside antibiotics exemplify the importance of innovation in healthcare. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…